NEW
Font size
WorksheetsUnit 6 Review
Total questions: 20
Worksheet time: 10mins
GLP-1 Agonists
(Incretin Mimetics) MOA
Increase insulin secretion, delay stomach emptying, and inhibit/decrease glucagon secretion, incretin mimetic
Increase glucagon secretion and decrease insulin sensitivity
Delay insulin secretion and increase stomach emptying
Inhibit incretin mimetics and increase glucagon secretion
Which of the following medications is used to treat Erectile Dysfunction?
sildenafil (Viagra®)
vardenafil (Levitra®)
Tadalafil (Cialis®)
sildenafil (Viagra®)
vardenafil (Levitra®)
Tadalafil (Cialis®)
Aspirin
Erectile Dysfunction SE
Headache
Flushing of skin
Rash
Nasal congestion
Mineralocorticoids MOA
Used to maintain water balance in the body; secreted by the outer layer of the adrenal gland
Inhibit the production of cortisol in the adrenal cortex
Stimulate the release of insulin from the pancreas
Increase the absorption of calcium in the intestines
Which of the following is classified as an Androgenic Drug?
Androderm®
Striant®
Androgel®
Androderm®
Striant®
Androgel®
Testosterone®
Thiazolidinediones (TZD’s)
MOA
Increases insulin receptor sensitivity
Decreases insulin receptor sensitivity
Inhibits glucose absorption in the intestines
Stimulates insulin secretion from the pancreas
What is misoprostol (Cytotec®)?
Prostaglandins
Antibiotics
Analgesics
Antidepressants
when glucose increases
insulin is released
glucagon is released
blood sugar decreases
glycogen is stored
Thyroid Medication SE
-increase in metabolism, weight loss, sweating
-headaches
-nausea
-tremors, nervousness
docusate sodium (Colace®)
docusate calcium (Surfak®)
Stool softeners
Laxatives
Antacids
Antidiarrheals
Alpha cells secrete
insulin
glucagon
somatostatin
cortisol
Cushing’s syndrome
-Excessive glucocorticoid production
-Decreased glucocorticoid production
-Increased mineralocorticoid production
-Excessive aldosterone production
Which of the following is an antacid?
calcium carbonate (Tums®)
sodium bicarbonate (Alka-Seltzer®)
magnesium hydroxide (Milk of Magnesia®)
aluminum hydroxide (Amphojel®)
Meglitinides MOA
Stimulates beta cells to release insulin (similar to sulfonylureas but with less side effects)
Inhibits glucose production in the liver
Increases insulin sensitivity in peripheral tissues
Delays gastric emptying to reduce postprandial glucose levels
H-2 Receptor Antagonist SE
Headache
Nausea
Dizziness
Constipation
Anterior Lobe (Adenohypophysis)
Stimulate release of hormones in the anterior lobe of the pituitary (tropic hormones)
Inhibit hormone production in the posterior lobe
Regulate blood sugar levels
Control the body's metabolism
NPH (Humulin N®, Novolin N®)
Short acting insulin therapy drugs
Long acting insulin therapy drugs
Intermediate acting insulin therapy drugs
Rapid acting insulin therapy drugs
Thiazolidinediones (TZD’s) SE
Edema
Weight gain
Hepatotoxicity
Nausea
Type 2 Diabetes pathophysiology
Non-insulin dependent
Insulin dependent
Acute onset
Common in children
SGLT2 Inhibitors MOA
Increases glucose reabsorption in the kidneys
Prevents glucose reabsorption, causing glucose excretion in the urine
Stimulates insulin secretion from the pancreas
Inhibits glucagon release from the liver
